90 related articles for article (PubMed ID: 24377586)
1. Luteolin, a bioflavonoid, attenuates azoxymethane-induced effects on mitochondrial enzymes in BALB/c mice.
Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6669-72. PubMed ID: 24377586
[TBL] [Abstract][Full Text] [Related]
2. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis.
Ashokkumar P; Sudhandiran G
Biomed Pharmacother; 2008 Nov; 62(9):590-7. PubMed ID: 18692983
[TBL] [Abstract][Full Text] [Related]
3. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis.
Pandurangan AK; Dharmalingam P; Sadagopan SK; Ganapasam S
Hum Exp Toxicol; 2014 Nov; 33(11):1176-85. PubMed ID: 24532706
[TBL] [Abstract][Full Text] [Related]
4. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice.
Pandurangan AK; Dharmalingam P; Ananda Sadagopan SK; Ganapasam S
Asian Pac J Cancer Prev; 2012; 13(4):1569-73. PubMed ID: 22799368
[TBL] [Abstract][Full Text] [Related]
5. Modulating effect of Withania somnifera on TCA cycle enzymes and electron transport chain in azoxymethane-induced colon cancer in mice.
Muralikrishnan G; Amanullah S; Basha MI; Dinda AK; Shakeel F
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):523-7. PubMed ID: 20136350
[TBL] [Abstract][Full Text] [Related]
6. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.
Pandurangan AK; Kumar SA; Dharmalingam P; Ganapasam S
Pharmacogn Mag; 2014 Apr; 10(Suppl 2):S306-10. PubMed ID: 24991108
[TBL] [Abstract][Full Text] [Related]
7. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling.
Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S
Toxicol Mech Methods; 2014 Jan; 24(1):13-20. PubMed ID: 24024667
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice.
Nagamine CM; Rogers AB; Fox JG; Schauer DB
Int J Cancer; 2008 Feb; 122(4):832-8. PubMed ID: 17957786
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
10. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis.
Takagi T; Nakano Y; Takekoshi S; Inagami T; Tamura M
Carcinogenesis; 2002 Jul; 23(7):1235-41. PubMed ID: 12117783
[TBL] [Abstract][Full Text] [Related]
11. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
[TBL] [Abstract][Full Text] [Related]
12. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.
Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T
Carcinogenesis; 2006 Jan; 27(1):162-9. PubMed ID: 16081511
[TBL] [Abstract][Full Text] [Related]
13. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
14. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW
Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis.
Papanikolaou A; Wang QS; Mulherkar R; Bolt A; Rosenberg DW
Carcinogenesis; 2000 Feb; 21(2):133-8. PubMed ID: 10657948
[TBL] [Abstract][Full Text] [Related]
16. Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge.
Manju V; Balasubramaniyan V; Nalini N
Cell Mol Biol Lett; 2005; 10(3):535-51. PubMed ID: 16217561
[TBL] [Abstract][Full Text] [Related]
17. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Femia AP; Dolara P; Caderni G
Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Biological Efficiency of Silver Nanoparticles Biosynthesized Using Croton tiglium L. Seeds Extract against Azoxymethane Induced Colon Cancer in Rats.
Aboulthana WM; Ibrahim NE; Osman NM; Seif MM; Hassan AK; Youssef AM; El-Feky AM; Madboli AA
Asian Pac J Cancer Prev; 2020 May; 21(5):1369-1389. PubMed ID: 32458646
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane.
Suzuki R; Kohno H; Sugie S; Tanaka T
Histol Histopathol; 2005 Apr; 20(2):483-92. PubMed ID: 15736053
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
